Frontiers in Anti-Infective Drug Discovery

Frontiers in Anti-Infective Drug Discovery

Volume: 4

Indexed in: Book Citation Index, Science Edition; BIOSIS Previews, Scopus, EBSCO, Ulrich's Periodicals Directory.

This eBook series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the eBook series covers a range of topics ...
[view complete introduction]

US $

*(Excluding Mailing and Handling)

Polysaccharide Deacetylases: New Antibacterial Drug Targets

Pp. 68-130 (63)

Stavroula Balomenou, Sofia Arnaouteli, Dimitris Koutsioulis, Vasiliki E. Fadouloglou and Vassilis Bouriotis


There is an urgent need to explore new targets and develop novel therapeutics due to the emergence of multi-drug resistant bacteria. Recently, selected members of Carbohydrate Esterase family 4 namely peptidoglycan and exopolysaccharide de-N-acetylases from bacterial pathogens have been identified as promising antibacterial drug targets. This chapter highlights the state of the art in their physiological roles, biochemical characterization, regulation, localization, structure determination and mechanism of action. Initial efforts and strategies that will guide the development of novel inhibitors against bacterial pathogens, including biofilm forming and spore forming ones, are also reviewed.


Biofilm formation, enzyme inhibitors, lysozyme resistance, peptidoglycan deacetylases, polysaccharide deacetylases, spore formation, virulence factors.


Department of Biology, Enzyme Biotechnology Group, University of Crete, PO Box 2208, Vasilika Vouton, 714 09, Heraklion, Crete, Greece.